New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DGCI has said.
from Videos https://ift.tt/35qyiG9
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment